Loading clinical trials...
Loading clinical trials...
A Randomized Trial of Lemborexant for the Prevention of Delirium After Cardiac Surgery (PROTEX): A Pilot Study
Conditions
Interventions
Lemborexant 5 mg
Control (placebo) group
Locations
1
Canada
St. Paul's Hospital
Vancouver, British Columbia, Canada
Start Date
May 1, 2025
Primary Completion Date
April 30, 2027
Completion Date
April 30, 2027
Last Updated
April 23, 2025
NCT07513974
NCT07418242
NCT05573633
NCT07411612
NCT07287345
NCT06474754
Lead Sponsor
University of British Columbia
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions